Código QR

Constructing a cell line-based treatment model for pancreatic adenocarcinoma patients receiving first-line second-line chemotherapies: a novel method in preclinical study

Objective: Approximately 80% of patients with pancreatic adenocarcinoma (PA) are diagnosed with locally advanced, unresectable, or metastatic disease at presentation. First-, second-, and third-line chemotherapies are beneficial for patients. Gemcitabine (GEM)-based regimens played an indispensable...

Descripción completa

Guardado en:
Autores principales: L. Wang, Y. Wang, Y. Liu, Y. Mu, Y. Zhang, Y. Song, X. Han, T. Zhang
Formato: Artigo
Lenguaje:Inglês
Publicado: Verduci Editore 2024-09-01
Colección:World Cancer Research Journal
Materias:
gemcitabine
pancreatic adenocarcinoma
first-line
second-line
Acceso en línea:https://www.wcrj.net/wp-content/uploads/sites/5/2024/09/e2835.pdf
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares